“`html

Pending Home Sales: A Stagnant September

In the latest report from the National Association of REALTORS®, September 2025 saw no change in pending home sales from the previous month, marking a 0.9% decline when compared year over year. This data provides a significant insight into the current state of the housing market, despite mortgage rates reaching a one-year low.
Lawrence Yun, the NAR Chief Economist, commented on the situation, stating that while contract signings matched the second-strongest pace of the year, they still fell short of the level needed for a healthy market. This is particularly noteworthy given the backdrop of a record-high stock market and increasing housing wealth during September. However, these positive economic indicators were not enough to counterbalance what appears to be a softening job market.
The Pending Home Sales Index (PHS), a leading indicator of housing activity, is based on signed real estate contracts for existing single-family homes, condos, and co-ops. This index typically leads Existing-Home Sales by a month or two, providing an early glimpse into future sales figures.
As we await the next release of data, scheduled for November 25, 2025, the market’s reaction to these figures will be closely watched. Will the housing market find the momentum it needs, or will the challenges in the job market continue to cast a shadow over potential growth? Only time will tell.
For a more detailed analysis, you can read the full news release.
“`

More Articles

Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!

The AI Boom in Cancer: Game-Changer or Just Hype?

The promise of artificial intelligence (AI) in the field of oncology is nothing short of revolutionary. As the world grapples with the complexities of cancer, AI is emerging as a potential game-changer in diagnostics, treatment personalization, and drug discovery.

By |January 15, 2025|Categories: Article, Healthcare, Technology|Tags: |0 Comments

HHS Unveils AI Strategic Plan to Revolutionize Healthcare

The U.S. Department of Health and Human Services (HHS) has unveiled its ambitious AI Strategic Plan, a comprehensive blueprint aimed at revolutionizing healthcare, human services, and public health through the transformative power of artificial intelligence.

By |January 15, 2025|Categories: Article, Artificial Intelligence, Healthcare|Tags: , |0 Comments

United States Naval Academy Class of 2024 Graduation

The ceremony was graced by the presence of three distinguished speakers, whose words of wisdom and encouragement left a lasting impression on the attendees.

By |January 14, 2025|Categories: Article, Education, Military|Tags: , |0 Comments

AI Certifications: The Key to Future-Proofing Your Career

In the fast-paced world of artificial intelligence (AI), staying current with the latest technological advancements is crucial for professionals aiming to excel in their careers. As businesses increasingly integrate AI into their operations, the demand for skilled AI experts is surging.

By |January 14, 2025|Categories: Article, Education, Technology|Tags: , |0 Comments

Telemedicine: A Digital Revolution in Healthcare Amid COVID-19

The year 2020 marked a significant turning point in the global healthcare landscape, as the COVID-19 pandemic accelerated the adoption of digital technologies such as telemedicine.

By |January 14, 2025|Categories: Article, Healthcare, Technology|Tags: , |0 Comments

Genomic Biomarkers Market Thrives with Personalized Medicine Boom

The genomic biomarkers market is witnessing a significant surge, driven by the burgeoning demand for personalized medicine. According to the latest report, the market is projected to grow to $14.09 billion by 2028, marking a compound annual growth rate (CAGR) of 17.4%. This approach not only optimizes treatment effectiveness but also minimizes side effects, making it a cornerstone of modern healthcare.